Applied Food Diagnostics Unveils Cannabis Pathogen Screen Test for Shiga-toxin Producing E. coli, Salmonella and Aspergillus

Applied Food Diagnostics, Inc., a food science solutions company, is pleased to announce the Cannabis Pathogen…

Simplex Health Launches FITNatal

Simplex Health, the leading provider of evidence-based medical nutrition therapies is thrilled to announce the launch…

Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19

Researchers from Hackensack Meridian University Medical Center and Berry Consultants, LLC, Austin, Texas have developed a new model…

Announcing Awards Of Community Heart & Soul® Seed Grants

Community Heart & Soul is pleased to award its first three $10,000 Seed Grants to Akron and Westfield, Iowa; Cambridge, Illinois; and Winchendon,…

Nektar Therapeutics Reports Second Quarter 2021 Financial Results

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2021. Cash and investments…

Relmada Therapeutics to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 10, 2021

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS),…

Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates

 Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer…

Apollo Medical Holdings, Inc. Reports Second Quarter 2021 Results

Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH),…

Life Time Launches Kids’ Versions of Most Popular Adult Group Exercise Classes

 Kids aged 5 to 13 can now experience some of Life Time’s most popular group exercise…

Accelerate Diagnostics Reports Second Quarter 2021 Financial Results

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June…